| abstract |
[Problem] To provide vaccine nanotechnology. The present invention provides compositions and systems for delivering nanocarriers to cells of the immune system. The present invention is capable of stimulating an immune response in T cells and / or B cells, and in some embodiments includes at least one immunomodulatory agent, and optionally includes at least one targeting moiety and Accordingly, a vaccine nanocarrier comprising at least one immunostimulatory agent is provided. The present invention provides a pharmaceutical composition comprising an inventive vaccine nanocarrier. The present invention provides methods for designing, manufacturing and using inventive vaccine nanocarriers and pharmaceutical compositions thereof. The present invention provides a method for the prevention and / or treatment of diseases, disorders and conditions, the method comprising administering at least one inventive vaccine nanocarrier to a subject in need thereof. To do. [Selection] Figure 1 |